Physician

Gnanamba V Kondagunta, MD

According to 2025 Medicare claims, Gnanamba Kondagunta, MD (NPI: 1265403208) practices hematology/oncology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Orange, NY. This provider's primary affiliated billing organization is CRYSTAL RUN HEALTHCARE PHYSICIANS LLP (NPI: 1952376410; TIN: 133843560) and primary practice location at 10941-9998.

Kondagunta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 795 traditional Medicare patients, billed 137,390 HCPCS/CPT codes, and received $2,910,544 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,255 prescription claims across 381 beneficiaries totaling $5,474,386 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 14 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $725,291 to $2,910,544. Similarly, Part D prescription costs have moved sharply higher in recent years, from $789,331 to $5,474,386. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,172 to $493.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.7M2015 Medicare payment: $725,291 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,344,296 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,872,517 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,732,952 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,803,651 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,441,686 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,832,973 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,460,657 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,743,634 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,910,544 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201558764,865$725,291
2016582110,443$1,344,296
2017620101,980$1,872,517
201861489,393$1,732,952
201971696,998$1,803,651
2020671115,149$2,441,686
2021687124,580$2,832,973
2022703174,995$3,460,657
2023803171,494$3,743,634
2024795137,390$2,910,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.7M$5.5M2015 Drug cost: $789,331 (USD; Tot_Drug_Cst)2016 Drug cost: $1,143,465 (USD; Tot_Drug_Cst)2017 Drug cost: $1,331,406 (USD; Tot_Drug_Cst)2018 Drug cost: $1,401,463 (USD; Tot_Drug_Cst)2019 Drug cost: $2,099,833 (USD; Tot_Drug_Cst)2020 Drug cost: $2,635,529 (USD; Tot_Drug_Cst)2021 Drug cost: $3,632,653 (USD; Tot_Drug_Cst)2022 Drug cost: $3,662,979 (USD; Tot_Drug_Cst)2023 Drug cost: $4,104,594 (USD; Tot_Drug_Cst)2024 Drug cost: $5,474,386 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152021,121$789,331
20162091,101$1,143,465
20172151,281$1,331,406
20182311,133$1,401,463
20192441,241$2,099,833
20202551,453$2,635,529
20212941,614$3,632,653
20223071,721$3,662,979
20233451,872$4,104,594
20243812,255$5,474,386

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.2K$6.4K2015 Medicare payment: $4,754 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $555 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $6,415 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,784 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $4,315 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,587 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $4,006 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R49$4,754
2016N/R11$555
2017N/R13$6,415
2018N/R11$3,784
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R66$4,315
2022N/R38$1,587
2023N/R14$4,006
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4041,057$101
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's4281,031$14
80053Blood test, comprehensive group of blood chemicals4081,284$10
36415Insertion of needle into vein for collection of blood sample4891,816$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4661,657$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide531,484$889,501
Abiraterone AcetateAbiraterone Acetate2006,000$526,299
NubeqaDarolutamide431,290$507,448
CalquenceAcalabrutinib Maleate391,170$506,745
LenvimaLenvatinib Mesylate16480$388,565

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Gnanamba V. Kondagunta, MD?

Tedicare shows public-source Medicare data for Gnanamba V. Kondagunta, MD (NPI 1265403208), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gnanamba V. Kondagunta, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gnanamba V. Kondagunta, MD?

Gnanamba V. Kondagunta, MD is linked to CRYSTAL RUN HEALTHCARE PHYSICIANS LLP (billing NPI 1952376410) in the available physician profile data.

Does Gnanamba V. Kondagunta, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.